Hydrochlorothiazide
Product Images NDC 76413-162

2 FDA label images from Central Texas Community Health Centers · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 76413-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Central Texas Community Health Centers, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hctz Structural Formula (Image 01)

Hctz Structural Formula (Image 01)
Chemical structure diagram showing the molecular structure of Hydrochlorothiazide. The structure includes a benzene ring with chlorine and sulfonamide functional groups attached, illustrating key atoms and bonds of the active ingredient Hydrochlorothiazide.*
FDA Label Image

Label Image (Lbl76413162)

Label Image (Lbl76413162)
A medication instruction label from Austin/Travis Co. Health & Human Services Dept. for Hydrochlorothiazide 25 mg tablets, quantity 30. Directions are to take one tablet by mouth daily, written in English and Spanish. The label includes the NDC 76413-162 and mentions the manufacturer TEVA. Batch, lot, and expiration fields are present but not clearly filled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.